ALG6-SLC22A15 Fusion FISH Probe
The ALG6-SLC22A15 Fusion FISH Probe is used to confirm a fusion of the ALG6 and SLC22A15 genes. The fusion of the ALG6 and SLC22A15 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ALG6-SLC22A15-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ALG6-SLC22A15-20-AQAQ | 20 (40 μL) | 200 μL |
|
ALG6 Gene Summary
This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the first glucose residue to the growing lipid-linked oligosaccharide precursor of N-linked glycosylation. Mutations in this gene are associated with congenital disorders of glycosylation type Ic. [provided by RefSeq, Jul 2008]
Gene Name: ALG6, Alpha-1,3-glucosyltransferase
Chromosome: CHR1: 63833260 -63904233
Locus: 1p31.3
SLC22A15 Gene Summary
Organic ion transporters, such as SLC22A15, transport various medically and physiologically important compounds, including pharmaceuticals, toxins, hormones, neurotransmitters, and cellular metabolites. These transporters are also referred to as amphiphilic solute facilitators (ASFs).[supplied by OMIM, Apr 2004]
Gene Name: Solute Carrier Family 22 Member 15
Chromosome: CHR1: 116519118 -116612675
Locus: 1p13.1
Gene Diseases
The ALG6 SLC22A15 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|